Stereotactic Ablative Radiation Therapy for Oligometastatic Ovarian Cancer Lymph Node Disease: The MITO-RT3/RAD Phase II Trial.
Macchia G, Campitelli M, Pezzulla D, Lucci S, Fodor A, Russo D, Balcet V, Bonome P, Durante S, Draghini L, Titone F, D'Agostino GR, Tamburo M, Ferioli M, Ippolito E, Tortoreto F, Caravatta L, De Felice F, Stefano AD, Fanelli M, Cilla S, Cosentino F, Marchetti C, Salutari V, Boccia S, Morganti AG, Gambacorta MA, Fagotti A, Pignata S, Scambia G, Ferrandina G, Deodato F.
Macchia G, et al. Among authors: morganti ag.
Int J Radiat Oncol Biol Phys. 2024 Sep 24:S0360-3016(24)03402-3. doi: 10.1016/j.ijrobp.2024.09.036. Online ahead of print.
Int J Radiat Oncol Biol Phys. 2024.
PMID: 39326506